| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/24/2008 | US7390635 selected from heavy chains, light chains and modified variable regions; breast cancer therapy; detecting using antigen and antibody complex; immunoassay, immunotherapy |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390492 Producing a passive immunity vaccine against Sarcocystis neurona by providing Sarcocystis neurona 16 kDa and 30 kDa antigens as determined by SDS polyacrylamide gel electrophoresis;immunizing mammal in mixture with adjuvant; removing serum; isolating antibodies; administering antibodies |
| 06/24/2008 | US7390491 Agents comprising midkine or an inhibitor thereof as active ingredient |
| 06/24/2008 | US7390490 Administering a monoclonal antibody that binds to CX3CR1 or fractalkine and inhibits chemotaxis of killer lymphocytes by suppressing an interaction between CX3CR1 and fractalkine; autoimmune diseases, diabetes, rheumatoid arthritis, and hepatitis |
| 06/24/2008 | US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis |
| 06/24/2008 | US7390487 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/24/2008 | US7390486 PRO4381 antibodies |
| 06/19/2008 | WO2008073598A2 Methods for improving antibody production |
| 06/19/2008 | WO2008073463A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | WO2008073300A2 Monoclonal antibodies against angptl3 |
| 06/19/2008 | WO2008073070A2 Antibodies to a spore specific glycosyl hydrolase |
| 06/19/2008 | WO2008072723A1 ANTI-Claudin-3 MONOCLONAL ANTIBODY, AND TREATMENT AND DIAGNOSIS OF CANCER USING THE SAME |
| 06/19/2008 | WO2008071974A2 Use of pi3k m-tor and akt inhibitors to induce f0xp3 expression and generate regulatory t cells |
| 06/19/2008 | WO2008071934A1 Treatment of cachexia |
| 06/19/2008 | WO2008071806A1 Antibodies against human cytomegalovirus (hcmv) |
| 06/19/2008 | WO2008071751A1 Delivery of binding molecules to induce immunomodulation |
| 06/19/2008 | WO2008071685A1 Polypeptides specific for complexes involved in receptor-mediated signaling, such as the il-6/il-6 receptor complex |
| 06/19/2008 | WO2008071394A1 Abeta antibody parenteral formulation |
| 06/19/2008 | WO2008051980A3 Methods of reducing phosphate absorption |
| 06/19/2008 | WO2008043777B1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 06/19/2008 | WO2008030505A3 Methods and compositions for the treatment of antibody mediated neuropathies |
| 06/19/2008 | WO2008027942A3 Combination hepatitis c virus antigen and antibody detection method |
| 06/19/2008 | WO2008017828A3 Antibodies specific for human cd98 heavy antigen |
| 06/19/2008 | WO2008008482A3 Altered br3-binding polypeptides |
| 06/19/2008 | WO2007146968A3 Single-chain multivalent binding proteins with effector function |
| 06/19/2008 | WO2007127335A3 Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways |
| 06/19/2008 | WO2007109321A3 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 06/19/2008 | US20080146785 Antibody against tumor specific antigen as target |
| 06/19/2008 | US20080146784 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 06/19/2008 | US20080146782 produced by the enzyme mediated formation of a conjugate between a glycosylated or non-glycosylated peptide and an enzymatically transferable saccharyl moiety that includes a modifying group, such as a polymeric modifying group such as poly(ethylene glycol), within its structure |
| 06/19/2008 | US20080146519 IL-14alpha RNA inhibitors and antibodies to IL-14alpha for treatment of autoimmune diseases and lymphomas |
| 06/19/2008 | US20080146508 Soluble cyclic analogues of beta amyloid peptide |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080146499 Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12 |
| 06/19/2008 | US20080146498 Diagnostic Agent For Ischemic Heart Disease Risk Group |
| 06/19/2008 | US20080145943 Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 06/19/2008 | US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/19/2008 | US20080145928 Nucleotide sequences coding transcription factor for use in prevention and treatment of cell proliferative disorders |
| 06/19/2008 | US20080145916 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 06/19/2008 | US20080145907 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
| 06/19/2008 | US20080145897 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, Isolated PEF protein, and methods for purifying and identifying |
| 06/19/2008 | US20080145870 Marker for Neuromyelitis Optica |
| 06/19/2008 | US20080145866 Modified human thymic stromal lymphopoietin |
| 06/19/2008 | US20080145865 Assays for rab5 activity |
| 06/19/2008 | US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis |
| 06/19/2008 | US20080145381 Multi-subtype FIV vaccines |
| 06/19/2008 | US20080145379 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 06/19/2008 | US20080145377 G-CSF Polypeptides And Uses Thereof |
| 06/19/2008 | US20080145374 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates |
| 06/19/2008 | US20080145367 Using interleukin specific immunoglobulin for treatment and prevention of imflammatory bone disorders |
| 06/19/2008 | US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents |
| 06/19/2008 | US20080145365 Human and mammalian stem cell-derived neuron survival factors |
| 06/19/2008 | US20080145364 Method for High Throughput Screening for Anitbodies and Proteins Inducing Apoptosis |
| 06/19/2008 | US20080145362 Antibody combination useful for tumor therapy |
| 06/19/2008 | US20080145361 Uses of mammalian cytokine; related reagents |
| 06/19/2008 | US20080145360 Lysolipid specific immunoglobulin for use in diagnosis, prevention and treatment of blood and cell proliferative disorders |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145347 p-Hyde sequences in the Rat |
| 06/19/2008 | US20080145346 Using modulators of heterogeneous nuclear ribonucleoprotein (hnRNP) K binding as therapeutic in treatment of viral diseases |
| 06/19/2008 | US20080145333 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 06/19/2008 | CA2672703A1 Antibodies against human cytomegalovirus (hcmv) |
| 06/19/2008 | CA2672595A1 Amino acid sequences that modulate the interaction between cells of the immune system |
| 06/19/2008 | CA2672581A1 Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same |
| 06/19/2008 | CA2672468A1 Human antibodies that bind cd70 and uses thereof |
| 06/19/2008 | CA2672386A1 Polypeptides specific for complexes involved in receptor-mediated signaling, such as the il-6/il-6 receptor complex |
| 06/19/2008 | CA2672229A1 Delivery of binding molecules to induce immunomodulation |
| 06/19/2008 | CA2672215A1 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | CA2672055A1 Treatment of cachexia |
| 06/19/2008 | CA2672049A1 Monoclonal antibodies against angptl3 |
| 06/19/2008 | CA2671971A1 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 06/19/2008 | CA2671968A1 Abeta antibody parenteral formulation |
| 06/19/2008 | CA2667502A1 Methods for improving antibody production |
| 06/19/2008 | CA2660038A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 06/18/2008 | EP1933150A1 Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, BCL-XL and BCL-W, and uses thereof |
| 06/18/2008 | EP1932917A2 Plant sterol acyltransferases |
| 06/18/2008 | EP1932916A1 Methods involving recombination of nucleic acid library members |
| 06/18/2008 | EP1932857A1 Preventive/remedy for cancer |
| 06/18/2008 | EP1932856A2 IL-8 inhibitors |
| 06/18/2008 | EP1932854A1 Lysosomal associated membrane protein (LAMP) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells |
| 06/18/2008 | EP1932539A2 Signal-1/Signal-2 bifunctional peptide inhibitors |
| 06/18/2008 | EP1931993A2 Means and methods for diagnosing endometriosis |
| 06/18/2008 | EP1931779A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 06/18/2008 | EP1931712A2 Modified antigen binding molecules with altered cell signaling activity |
| 06/18/2008 | EP1931711A1 Antibodies against 25-hydroxyvitamin d |
| 06/18/2008 | EP1931710A2 Engineered anti-il-23 antibodies |
| 06/18/2008 | EP1931709A2 Fc variants with optimized fc receptor binding properties |
| 06/18/2008 | EP1931700A1 FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF |
| 06/18/2008 | EP1931697A2 Il-17a and il-17f antagonists and methods of using the same |
| 06/18/2008 | EP1931216A1 Immunoglobulin and fatty acids |
| 06/18/2008 | EP1257648B1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 06/18/2008 | EP1198479B1 Neovascular-targeted immunoconjugates |
| 06/18/2008 | EP1115746B1 Antibodies to mammalian langerhans cell antigen and their uses |
| 06/18/2008 | EP1064027B1 Apo-2 ligand-anti-her-2 antibody synergism |
| 06/18/2008 | CN101203607A Anti-CD-20 monoclonal antibody |
| 06/18/2008 | CN101203532A Antibodies against candida antigens |
| 06/18/2008 | CN101203247A Targeted chimeric molecules for cancer therapy |
| 06/18/2008 | CN101203242A Method for treating dementia or alzheimer's disease by CD2O antibody |